Literature DB >> 18566330

Induction of proliferation and monocytic differentiation of human CD34+ cells by CD137 ligand signaling.

Dongsheng Jiang1, Pei Shan Eunice Yue, Daniela Drenkard, Herbert Schwarz.   

Abstract

CD137 is a member of the tumor necrosis factor receptor family and is involved in the regulation of activation, proliferation, differentiation, and cell death of leukocytes. Bidirectional signaling exists for the CD137 receptor/ligand system, as CD137 ligand, which is expressed as a transmembrane protein, can also transduce signals into the cells on which it is expressed. In this study, we have identified expression of CD137 in human bone marrow and expression of CD137 ligand on a subset of CD34+ cells. Cross-linking of CD137 ligand on CD34+ cells by CD137 ligand agonists induces activation, prolongation of survival, proliferation, and colony formation. CD137 ligand agonists induce differentiation of early hematopoietic progenitor cells to colony-forming units-granulocyte/macrophage and subsequently to monocytes and macrophages but not to dendritic cells. These data uncover a novel function of CD137 and CD137 ligand by showing their participation in the growth and differentiation of hematopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566330     DOI: 10.1634/stemcells.2008-0158

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  20 in total

1.  Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs.

Authors:  Takashi Onoe; Hannes Kalscheuer; Meredith Chittenden; Guiling Zhao; Yong-Guang Yang; Megan Sykes
Journal:  J Immunol       Date:  2010-05-10       Impact factor: 5.422

2.  Cross-linking of CD137 ligand modulates immune responses of thioglycollate-elicited mouse peritoneal macrophages.

Authors:  Jun-Sang Bae; Hyeong-Sup Kim; Jae Hong Park; Sang-Hyuk Park; Hyeon-Woo Lee
Journal:  Inflamm Res       Date:  2010-12-24       Impact factor: 4.575

Review 3.  CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses.

Authors:  Bhushan Dharmadhikari; Meihui Wu; Nur Sharalyn Abdullah; Sakthi Rajendran; Nur Diana Ishak; Emily Nickles; Zulkarnain Harfuddin; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2015-11-11       Impact factor: 8.110

4.  CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses.

Authors:  Zulkarnain Harfuddin; Shaqireen Kwajah; Adrian Chong Nyi Sim; Paul Anthony Macary; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2013-11-11       Impact factor: 8.110

5.  Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.

Authors:  Emily Nickles; Bhushan Dharmadhikari; Li Yating; Robert J Walsh; Liang Piu Koh; Michelle Poon; Lip Kun Tan; Ling-Zhi Wang; Yvonne Ang; Yugarajah Asokumaran; Wan Qin Chong; Yiqing Huang; Kwok Seng Loh; Joshua Tay; Ross Soo; Mickey Koh; Liam Pock Ho; Marieta Chan; Madelaine Niam; Melissa Soh; Yen Hoon Luah; Chwee Ming Lim; Nivashini Kaliaperumal; Veonice B Au; Najwa Binte Said Nasir Talib; Reina Sng; John E Connolly; Boon Cher Goh; Herbert Schwarz
Journal:  Cancer Immunol Immunother       Date:  2021-10-18       Impact factor: 6.968

6.  Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling.

Authors:  Charles Gullo; Liang Kai Koh; Wan Lu Pang; Kian Tong Ho; Shi Hao Tan; Herbert Schwarz
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

7.  Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration.

Authors:  Young-Mi Kim; Hye Kyung Kim; Hyo Jin Kim; Hee-Woo Lee; Seong-A Ju; Beom K Choi; Byoung S Kwon; Bong-Seon Kim; Jae-Bong Kim; Young-Tak Lim; Sik Yoon
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

8.  CD137-CD137 Ligand Interactions in Inflammation.

Authors:  Byungsuk Kwon
Journal:  Immune Netw       Date:  2009-06-30       Impact factor: 6.303

9.  CD137 is induced by the CD40 signal on chronic lymphocytic leukemia B cells and transduces the survival signal via NF-κB activation.

Authors:  Yukana Nakaima; Ken Watanabe; Takatoshi Koyama; Osamu Miura; Tetsuya Fukuda
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

10.  CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.

Authors:  Yee Andy Yeo; Julia M Martínez Gómez; J Ludovic Croxford; Stephan Gasser; Eng-Ang Ling; Herbert Schwarz
Journal:  J Neuroinflammation       Date:  2012-07-16       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.